Abstract-Influences of central alpha-2 adrenergic agonists on thyrotropin-releasing hormone (TRH)-stimulated gastric acid secretion were examined in the perfused stomach of anesthetized rats. Clonidine, an alpha-2 adrenergic agonist, given subcutaneously or intracerebroventricularly inhibited the gastric acid secretion stimulated by intracerebroventricular TRH. Intracerebroventricular injection of norepinephrine tended to reduce the acid secretion, while phenylephrine, serotonin and quipazine (serotonin agonist) did not influence the acid secretion. Sub cutaneous clonidine enhanced the acid secretion peripherally stimulated by electrical vagus stimulation.
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The inhibitory effect of clonidine on TRH-induced acid secretion was reversed by yohimbine, an alpha-2 adrenergic antagonist, and phentolamine.
In conclusion, the present study suggests that the central alpha-2 adrenergic receptor system participates in the TRH-mediated central nervous system control of gastric acid secretion in anesthetized rats. 
Materials and Methods
Male Wistar rats (ST. substrain from Sankyo Lab. Co., Ltd.), weighing 220 250 g, were anesthetized with urethane (1 .25 g/kg, i.p.) after a 24 hr fast, but were allowed free access to water. A gastric acid secretion assay was performed as described previously (7). Total amount of the secreted acid was expressed in terms of /teq HCI/60 min per animal. Basal secretion was low and almost constant during the experimental periods. Therefore, the data indicate the value of acid output after drug treatments subtracted by the respective basal secretion. Intracerebroven tricular drug administration was carried out by the technique of Noble et al. (14) . The vagus nerve was stimulated by a pair of platinum electrodes over a time period of 10 min as in our earlier study (15). Vagus stimulation was repeated at about 60-90 min intervals. All drugs were dissolved in saline and administered subcutaneously or intra peritoneally in a volume of 1 ml/kg. The volume of all intracerebroventricular injections except TRH (10 ,el/rat) was 5 ,el/rat. Doses of drugs are expressed as the amount of salt.
Drugs: Drugs used were clonidine HCI (Tokyo Kasei), dl-norepinephrine HCI (Nakarai), phentolamine (Ciba), phenyl ephrine HCI (Tokyo Kasei), quipazine maleate (Miles Lab.), serotonin creatinine sulfate (Merck), thyrotropin-releasing hormone (Pro tein Res. Foundation), urethane (Nakarai) and yohimbine HCI (Nakarai).
Statistical analysis: All data are presented as mean+S.E.
Data were analyzed by Student's t-test and a paired t-test. All data differences were considered significant at P<0.05 or P<0.01. gastric acid secretion. Ordinate: acid output per 2 min. Abscissa: time, chart speed 1 cm/10 min. TRH (10 pg/rat) was intracerebroventricularly injected twice into one rat. Clonidine (CND, mg/kg, s.c.) was given 15 min before the 2nd TRH infection. (Table 2) . Clonidine (0.5 mg/kg) did not increase basal secretion in the preparations in which the vagus nerve was cut. Figure 3 summarizes the influences of alpha-adrenergic blocking agents on the antisecretory effects of intracerebroventricular clonidine in TRH-treated rats. Pretreatment with yohimbine (2.5 mg/kg, i.p.) or phentol amine (1 mg/kg, i.p.) partly reversed the action of clonidine. (8) and of the inhibitory effect of clonidine on 2-deoxy-D glucose or insulin-stimulated acid secretion (9-11).
On the other hand, the potentiating effect of clonidine on vagal stimulation-induced acid secretion can be due to peripheral actions. This drug enhanced bethanechol-induced (10, 11, 23) and basal (9-11) acid secretion. Since the stimulatory effect of clonidine might be mediated by histamine (10, 11, 24, 25), the potentiating effect of clonidine may be explained by the hypothesis that endo genous agonists such as acetylcholine, hista mine and gastrin stimulate their specific receptors to produce synergistic effects on acid secretion (26) .
Some authors postulated that in the rat, 5HT is an inhibitory neurotransmitter in the amygdala for gastric acid secretion (27) . 5HT given intracerebroventricularly reduced acid secretion more strongly than by the intra peritoneal route (28) . These facts have led us to examine the central serotonergic as well as noradrenergic inhibitory mechanisms in the TRH-induced gastric acid secretion. However, the acid secretion was not in fluenced by intracerebroventricular 5HT or quipazine, a central serotonergic agonist (29, 30) , in the present study.
Clonidine has dual actions (increasing and decreasing) on blood pressure which have both peripheral and central origins (31, 32) . It has been reported that gastric acid secretion did not decrease in reserpinized rats with low blood pressure (33) , and there were no correlations between the influences of some adrenergic drugs on gastric secretion and on hemodynamics (34) . These results suggest that blood pressure changes must not inter fere with gastric secretion in the present study. 
